GLP-3 / Cagri
GLP-3 / Cagri, 10mg / 2mg to 12.5mg / 2.5mg from $95. A triple-receptor incretin compound with an amylin analog. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This is a blend. GLP-3 RT and Cagri are combined in a single vial: 10 mg of GLP-3 RT and 2 mg of Cagri. Both appear in metabolic research, but they act on different receptor systems. GLP-3 RT is a triple agonist at the GLP-1, GIP and glucagon receptors. Cagri is a long-acting amylin analogue that acts on amylin and calcitonin receptors. Researchers use blends to compare combined conditions against single compounds.
GLP-3 RT binds GLP-1, GIP and glucagon receptors. Published characterisation describes glucose-dependent insulin secretion, appetite-pathway signalling and hepatic energy expenditure in study models.
Cagri is a long-acting amylin analogue. It activates amylin receptors and the calcitonin receptor, with satiety signalling, gastric emptying and post-meal glucagon as measured endpoints.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | GLP-3 / Cagri |
| Category | Peptide Blends |
| Lot Number | MBP-2817 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!